Fatal Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer: A Clinical Case of Rare Oncological Emergency.

Colon cancer Spontaneous tumor lysis syndrome Tumor lysis syndrome

Journal

Case reports in gastroenterology
ISSN: 1662-0631
Titre abrégé: Case Rep Gastroenterol
Pays: Switzerland
ID NLM: 101474819

Informations de publication

Date de publication:
Historique:
received: 20 02 2020
accepted: 30 03 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Tumor lysis syndrome (TLS) is a potentially life-threatening complication of chemotherapy. It usually occurs in rapidly proliferating hematological malignancies. TLS is deemed spontaneous (STLS) when it occurs prior to any cytotoxic or definite treatment. STLS is extremely rare in solid tumors. Here, we report a rare case of fatal STLS in a 47-year-old woman diagnosed with metastatic colon cancer. The patient developed acute renal failure with anuria, electrolyte disturbances, and metabolic acidosis before initiating chemotherapy. Despite appropriate management of TLS, including renal replacement therapy, she died within a few days from multiorgan failure. Only few other case reports of STLS associated with colon cancer have been reported in the literature.

Identifiants

pubmed: 32508557
doi: 10.1159/000507648
pii: crg-0014-0255
pmc: PMC7250380
doi:

Types de publication

Case Reports

Langues

eng

Pagination

255-260

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have conflicts of interest to declare. The authors declare that they have no competing interests.

Références

Rare Tumors. 2014 Jun 13;6(2):5389
pubmed: 25002953
BMJ Case Rep. 2014 Sep 24;2014:
pubmed: 25253481
Clin Oncol (R Coll Radiol). 2006 Dec;18(10):773-80
pubmed: 17168213
Am J Hematol. 1994 Oct;47(2):129-31
pubmed: 8092128
Onkologie. 2010;33(10):498-9
pubmed: 20926895
J Investig Med High Impact Case Rep. 2015 Aug 25;3(3):2324709615603199
pubmed: 26904699
Support Cancer Ther. 2005 Apr 1;2(3):188-91
pubmed: 18628171
CJEM. 2018 Oct;20(S2):S41-S43
pubmed: 28893339
Br J Haematol. 2015 Jun;169(5):661-71
pubmed: 25876990
Br J Haematol. 2004 Oct;127(1):3-11
pubmed: 15384972
Clin Case Rep. 2017 Nov 13;5(12):2121-2126
pubmed: 29225869
J Gastrointest Cancer. 2019 Sep;50(3):668-673
pubmed: 29691710
Clin Colorectal Cancer. 2014 Sep;13(3):e5-e11
pubmed: 25065654
J Clin Oncol. 2008 Jun 1;26(16):2767-78
pubmed: 18509186
Am J Med Sci. 2003 Jan;325(1):38-40
pubmed: 12544084

Auteurs

Inna Shaforostova (I)

Department of Haematology, Haemostasiology, Oncology and Pneumology, Albert-Schweitzer Campus 1, Muenster, Germany.

Robert Fiedler (R)

Department of Radiology, Hospital Harzklinikum Dorothea Christiane Erxleben GmbH, Wernigerode, Germany.

Martina Zander (M)

Department of Pathology, Hospital Harzklinikum Dorothea Christiane Erxleben GmbH, Quedlinburg, Germany.

Johannes Pflumm (J)

Department of Internal Medicine, Hospital Harzklinikum Dorothea Christiane Erxleben GmbH, Wernigerode, Germany.

Wolfgang Josef März (WJ)

Department of Internal Medicine, Hospital Harzklinikum Dorothea Christiane Erxleben GmbH, Wernigerode, Germany.

Classifications MeSH